Healthcare provider profile · identity verified

Don R Roller, M.D.

Family Practice · TULSA, OK · NPI 1871577940

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Ezetimibe	Ezetimibe	245	74
Rosuvastatin Calcium	Rosuvastatin Calcium	205	62
Atorvastatin Calcium	Atorvastatin Calcium	184	54
Levothyroxine Sodium	Levothyroxine Sodium	141	41
Omeprazole	Omeprazole	91	26
Telmisartan	Telmisartan	91	28
Metoprolol Succinate	Metoprolol Succinate	87	27
Amlodipine Besylate	Amlodipine Besylate	82	26
Tramadol Hcl	Tramadol Hcl	71	18
Lisinopril	Lisinopril	64	20
Fenofibrate	Fenofibrate Nanocrystallized	59	19
Repatha Sureclick	Evolocumab	59	suppressed
Meloxicam	Meloxicam	57	20
Tamsulosin Hcl	Tamsulosin Hcl	55	15
Zolpidem Tartrate	Zolpidem Tartrate	54	14
Jardiance	Empagliflozin	53	11
Irbesartan	Irbesartan	49	12
Gabapentin	Gabapentin	48	14
Metformin Hcl Er	Metformin Hcl	46	17
Carvedilol	Carvedilol	44	14
Synthroid	Levothyroxine Sodium	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	43	15
Praluent Pen	Alirocumab	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	18
Trazodone Hcl	Trazodone Hcl	41	12
Alprazolam	Alprazolam	40	11
Doxycycline Hyclate	Doxycycline Hyclate	39	35
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Eliquis	Apixaban	39	suppressed
Allopurinol	Allopurinol	36	12
Losartan Potassium	Losartan Potassium	36	11
Sertraline Hcl	Sertraline Hcl	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Trulicity	Dulaglutide	34	suppressed
Azelastine Hcl	Azelastine Hcl	33	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	26
Potassium Chloride	Potassium Chloride	32	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Finasteride	Finasteride	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Chlorthalidone	Chlorthalidone	29	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Ozempic	Semaglutide	28	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Prednisone	Prednisone	26	23
Valacyclovir	Valacyclovir Hcl	26	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	23
Edarbi	Azilsartan Medoxomil	23	suppressed
Furosemide	Furosemide	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Torsemide	Torsemide	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Valsartan	Valsartan	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Estradiol (Twice Weekly)	Estradiol	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Ramipril	Ramipril	16	suppressed
Metformin Hcl	Metformin Hcl	15	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Azithromycin	Azithromycin	14	12
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error